Eastwood Bio-Medical Canada Inc Total Liabilities
Eastwood Bio-Medical Canada Inc total liabilities. Based on the latest financial reports, Eastwood Bio-Medical Canada Inc (EBM) has total liabilities worth CA$1.98 Million CAD (≈ $1.43 Million USD) as of April 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Eastwood Bio-Medical Canada Inc liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Eastwood Bio-Medical Canada Inc (2013–2025)
Total liabilities of Eastwood Bio-Medical Canada Inc from 2013 to 2025. This chart illustrates how Eastwood Bio-Medical Canada Inc's total liabilities have evolved over time, based on quarterly financial data.
Eastwood Bio-Medical Canada Inc Competitors by Total Liabilities
The table below lists competitors of Eastwood Bio-Medical Canada Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
CURATIS N AG
SW:CURN
|
Switzerland | CHF9.96 Million |
|
Medtecs International Corporation Ltd DRC
TW:9103
|
Taiwan | NT$44.00 Million |
|
AVer Information Inc
TW:3669
|
Taiwan | NT$1.12 Billion |
|
Fabryki Mebli Forte S.A.
WAR:FTE
|
Poland | zł495.26 Million |
|
Immobile
WAR:GKI
|
Poland | zł834.88 Million |
|
Data Communications Management Ltd
TO:DCM
|
Canada | CA$321.00 Million |
|
Agrify Corp
NASDAQ:AGFY
|
USA | $103.43 Million |
|
Sao Ta Foods JSC
VN:FMC
|
Vietnam | ₫1.79 Trillion |
Liability Composition Analysis (2013–2025)
This chart breaks down Eastwood Bio-Medical Canada Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see how large is Eastwood Bio-Medical Canada Inc's balance sheet.
Liquidity & Leverage Metrics
Eastwood Bio-Medical Canada Inc Total Liabilities Ratios Explained
Eastwood Bio-Medical Canada Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.05 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.15 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 7.47 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Eastwood Bio-Medical Canada Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Eastwood Bio-Medical Canada Inc (2013–2025)
The table below shows the annual total liabilities of Eastwood Bio-Medical Canada Inc from 2013 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-10-31 | CA$1.85 Million ≈ $1.34 Million |
+17.65% |
| 2024-10-31 | CA$1.57 Million ≈ $1.14 Million |
+18.12% |
| 2023-10-31 | CA$1.33 Million ≈ $962.05K |
+51.35% |
| 2022-10-31 | CA$878.73K ≈ $635.66K |
+5.18% |
| 2021-10-31 | CA$835.44K ≈ $604.35K |
+76.21% |
| 2020-10-31 | CA$474.10K ≈ $342.96K |
+41.22% |
| 2019-10-31 | CA$335.73K ≈ $242.86K |
-7.11% |
| 2018-10-31 | CA$361.41K ≈ $261.44K |
+548.22% |
| 2017-10-31 | CA$55.76K ≈ $40.33K |
+56.77% |
| 2016-10-31 | CA$35.56K ≈ $25.73K |
-63.74% |
| 2015-10-31 | CA$98.08K ≈ $70.95K |
+9.98% |
| 2014-10-31 | CA$89.19K ≈ $64.52K |
-97.72% |
| 2013-10-31 | CA$3.92 Million ≈ $2.83 Million |
-- |
About Eastwood Bio-Medical Canada Inc
Eastwood Bio-Medical Canada Inc. markets, develops research, and distributes natural health products under the Eleotin brand in Canada, the United States, and Asia. The company distributes Eleotin, which provides natural remedies for metabolic disorders, such as blood glucose disorders, hypertension, and obesity. It also offers Eleotin A 700 for the treatment for spleen deficiency, lack of appeti… Read more